Jun Gong, Medical Oncologist and Researcher at Cedars-Sinai Medical Center, posted on X:
“Rand PhII trial of HB1801 (albumin-bound taxotere) vs taxotere in adv G/GEJ adenocarcinoma after at least 1L platinum-based chemo numerical but no significant difference in PFS at ASCO GI25.”
